Leap Health

About Leap Health

The buyer is a self-funded employer paying for infusion drugs such as Keytruda, Ocrevus and Entyvio: Leap Health sells it a benefit that removes provider markups on those drugs and gives each member a care guide who books the infusion at home or at a nearby center, and its site claims savings of up to 60%. Most deals reach employers through intermediaries, so the commercial team splits into regional enterprise sales, channel relationships with consultants, brokers, TPAs, stop-loss carriers, PBMs and health plans, and a life sciences group facing drug makers, specialty pharmacies and infusion centers on the supply side. Seven of 23 openings carry sales titles: a regional VP of enterprise sales who carries a region of employers with 5,000 or more members, a director of consultant relations who owns the pipeline sourced from firms such as Mercer, WTW, Aon, Gallagher and Lockton, an SVP who builds the health plan partner channel under the chief commercial officer, and a senior solutions architect who designs implementations on pre-sale deals without carrying a quota. The life sciences group adds a partner success manager with a book of manufacturer and specialty pharmacy partners and a director who models drug acquisition costs and channel pricing, and the seventh is a physician medical director for clinical partnerships. All seven are remote roles in the US.